Although a more thorough investigation of the joint impact of these mutations on multiple sclerosis is warranted, GLI-1 is a therapeutic target of much interest in cancer, including through its interaction with SUFU, suggesting a starting point for further research. The gene discussed is SUFU; the disease is multiple sclerosis.